4 Urgent Superbugs Spreading in the US This Winter

Winter brings more indoor contact, seasonal respiratory illness, and increased demand on hospitals and clinics. These conditions can complicate infection control, but they do not mean every winter illness is caused by an antibiotic-resistant pathogen.

The informal term superbug usually describes a germ that resists one or more medicines used to treat infection. Some resistant organisms spread mainly in healthcare settings, while others circulate in communities, food systems, animals, or the environment.

Four organisms deserve particular attention in the United States: carbapenem-resistant Enterobacterales (CRE), carbapenem-resistant Acinetobacter baumannii (CRAB), Candida auris, and drug-resistant Neisseria gonorrhoeae. The Centers for Disease Control and Prevention classifies these organisms among serious or urgent antimicrobial-resistance threats, although their transmission patterns and clinical risks differ (Source 7).

What Is Antimicrobial Resistance?

Antimicrobial resistance occurs when germs develop the ability to survive medicines designed to kill them or stop their growth. The person does not become resistant; the germ becomes resistant (Source 5).

Resistance affects different organisms:

• Bacteria can resist antibiotics.
• Viruses can resist antiviral medicines.
• Fungi can resist antifungal drugs.
• Parasites can resist antiparasitic treatments.

Antibiotics do not treat influenza, the common cold, or most other viral infections. Using an antibiotic unnecessarily can cause side effects and create pressure that favors resistant bacteria.

A resistant infection may require a different medicine, a longer treatment course, intravenous therapy, specialist supervision, or hospitalization. Treatment depends on the infection site, the patient’s condition, the organism, and local resistance patterns.

Four Superbugs Requiring Attention

1. Carbapenem-Resistant Enterobacterales

CRE are bacteria in the Enterobacterales family that resist carbapenems. The family includes organisms such as Escherichia coli and Klebsiella pneumoniae. CRE can cause urinary-tract infections, pneumonia, wound infections, bloodstream infections, and meningitis.

Carbapenems are often reserved for serious infections caused by bacteria resistant to other antibiotics. When CRE also resists additional drug classes, treatment options may become very limited. Some CRE produce enzymes that destroy carbapenem antibiotics, and certain resistance mechanisms can move between bacterial species.

The most severe infections affect the bloodstream, lungs, or other normally sterile body sites. Bloodstream infections can lead to sepsis, organ failure, and death. Healthcare-associated transmission is a major concern, particularly in hospitals and long-term-care facilities (Source 7).

CRE can spread through contaminated hands, surfaces, equipment, and bodily fluids. Risk is higher for people with prolonged hospital stays, invasive devices, open wounds, recent surgery, or repeated antibiotic exposure.

Symptoms depend on the infection site and may include fever, chills, confusion, cough, shortness of breath, painful urination, flank pain, wound drainage, or worsening redness and swelling. Laboratory culture and susceptibility testing help clinicians determine which medicines may work. Colonization does not always mean active infection and does not automatically require treatment.

2. Carbapenem-Resistant Acinetobacter baumannii

CRAB is a bacterium that can cause pneumonia, bloodstream infections, urinary infections, and wound infections. It is especially associated with hospitals, intensive-care units, and long-term-care facilities.

CRAB can survive on surfaces for extended periods. It may resist carbapenems and several other antibiotics, leaving clinicians with few effective options. Some treatments can cause significant side effects or require close monitoring.

Transmission can occur through contaminated hands, surfaces, ventilators, catheters, and other medical equipment. Patients may continue to carry the organism after discharge, making accurate medical histories and infection-control precautions important during future care.

Risk factors include mechanical ventilation, prolonged hospitalization, serious underlying illness, open wounds or burns, invasive devices, intensive-care treatment, and recent exposure to broad-spectrum antibiotics. Symptoms may include fever, breathing difficulty, cough, wound changes, confusion, or signs of sepsis.

3. Candida auris

Candida auris is a drug-resistant fungus that can cause invasive infections, including bloodstream, wound, and ear infections. It can also colonize the skin without causing illness.

Unlike many common forms of Candida, C. auris can spread efficiently in healthcare settings and persist on surfaces and equipment. The CDC identifies it as an urgent public-health concern because some strains resist two or more major classes of antifungal medicines.

There is no universal rule that C. auris transmission increases during winter. Concern may rise when hospitals and long-term-care facilities experience higher patient volumes, staff pressure, and more frequent transfers. These factors can complicate infection control but do not prove a seasonal pattern.

Patients may carry the organism without symptoms and transmit it through contaminated surfaces, equipment, or skin. Invasive infection can cause fever and chills that do not improve with treatment for another suspected infection. The risk is greatest for people with substantial healthcare exposure, central lines or other invasive devices, recent surgery, or repeated antibiotic or antifungal treatment.

Healthcare facilities may use screening, contact precautions, dedicated equipment, environmental disinfection, and targeted laboratory testing. Individuals should follow instructions about wound care, hand hygiene, and medical-device care.

4. Drug-Resistant Neisseria gonorrhoeae

Neisseria gonorrhoeae causes gonorrhea, a sexually transmitted infection. Some strains have developed resistance to antibiotics that were previously effective, raising concern about future treatment failures.

Gonorrhea can infect the genitals, rectum, throat, and eyes. Many infections cause few or no symptoms, particularly some throat and rectal infections. Untreated infection can cause pelvic inflammatory disease, infertility, ectopic pregnancy, disseminated infection, and complications in newborns.

Drug-resistant gonorrhea can spread through sexual contact and circulate without detection when people have no symptoms. Resistance patterns vary by location and strain, so clinicians rely on current public-health guidance, diagnostic testing, and resistance surveillance.

Molecular tests, including nucleic acid amplification tests, can identify infection. Culture and susceptibility testing may be important when treatment failure is suspected, symptoms persist, or resistance requires investigation. Patients should not use leftover antibiotics or medication prescribed for another infection. Sexual partners may also need evaluation and treatment.

Avoid sexual contact until healthcare instructions indicate that treatment is complete and transmission risk has been addressed. Condoms and regular testing reduce risk but do not eliminate it.

How Superbugs Differ From Seasonal Illnesses

Antibiotics do not treat influenza, the common cold, or most other viral respiratory infections. A cough or fever alone does not establish the need for an antibiotic. A clinician may prescribe one when a bacterial infection is diagnosed or strongly suspected.

Resistance does not always mean an infection is untreatable. Many resistant infections remain treatable with another medicine, although treatment may require intravenous therapy, additional monitoring, a longer recovery, or specialist care.

Use antibiotics only when prescribed and follow the directions exactly (Source 5).

Who Is Most Vulnerable?

Higher-risk groups include:

• Older adults
• Newborns and young children
• People with weakened immune systems
• People with chronic lung, kidney, liver, or metabolic disease
• Patients receiving cancer treatment
• People recently hospitalized or undergoing surgery
• Patients with catheters, central lines, ventilators, or other medical devices
• People with recent or repeated antimicrobial exposure

Risk depends on the pathogen, infection site, immune response, existing health conditions, and access to prompt diagnosis. Belonging to a risk group does not mean infection is inevitable; it means complications may be more likely if infection occurs.

How to Reduce Risk This Winter

• Take prescriptions exactly as directed.
• Do not share medicines or save leftover antibiotics.
• Do not take another person’s prescription.
• Ask a pharmacist how to dispose of unused medicine.
• Wash hands regularly with soap and water.
• Use alcohol-based sanitizer when handwashing is unavailable.
• Keep cuts clean and covered.
• Follow food-safety practices.
• Stay current on recommended vaccines.
• Follow infection-control instructions in hospitals and clinics.
• Tell healthcare professionals about recent hospital stays, procedures, travel, and antimicrobial use.
• Follow instructions for wound and medical-device care.
• Complete recommended follow-up testing.

When to Seek Medical Care

Contact a healthcare professional for a worsening infection, persistent or recurring fever, increasing wound redness or swelling, new drainage, trouble breathing, severe weakness, confusion, or dehydration.

Seek emergency care for severe breathing difficulty, bluish lips, fainting, sudden confusion, or rapidly worsening illness.

Only a qualified clinician can determine whether symptoms reflect an infection, whether antimicrobial treatment is needed, and whether resistance testing is appropriate.

What Clinicians and Public-Health Officials Are Doing

Public-health laboratories and healthcare systems monitor resistant organisms through case reporting, outbreak investigations, screening, cultures, and susceptibility testing. These systems help identify transmission and guide treatment.

Antimicrobial stewardship means using the right medicine, dose, route, and duration when treatment is needed. Stewardship protects patients and preserves effective medicines for future infections.

Healthcare facilities may use screening, isolation precautions, environmental cleaning, equipment disinfection, vaccination, and staff training. Effective control combines diagnosis, treatment, hygiene, surveillance, and communication.

Conclusion

Antimicrobial resistance is a serious public-health problem, not a reason for panic. CRE, CRAB, Candida auris, and drug-resistant gonorrhea differ in how they spread, whom they affect, and how clinicians manage them.

Resistant germs can make infections harder to treat, but resistance does not always mean that no treatment exists. Hand hygiene, vaccination, wound care, testing, infection prevention, and appropriate prescribing all reduce risk. Seek medical advice for concerning symptoms and use antimicrobial medicines only as directed.

Frequently Asked Questions

What are superbugs?

Superbugs are germs that resist one or more medicines used to treat infection. The term most often describes antibiotic-resistant bacteria but can also refer to drug-resistant fungi, viruses, or parasites.

Are superbugs more common in winter?

Some infection risks can increase during winter because people spend more time indoors and healthcare systems face higher seasonal demand. The pattern depends on the pathogen. Winter does not automatically cause every superbug to spread more widely.

Can antibiotics treat a superbug infection?

Some resistant infections remain treatable with other medicines. Treatment depends on laboratory results, the infection site, severity, medical history, and local resistance patterns.

How can people avoid antibiotic resistance?

Use antibiotics only when prescribed, take them exactly as directed, avoid leftover or shared medicines, wash hands, maintain recommended vaccinations, practice safe food handling, and prevent infections when possible.

Do antibiotics help with colds or flu?

No. Antibiotics treat certain bacterial infections, not influenza or the viruses that cause most colds. A clinician may prescribe an antibiotic when a bacterial infection is diagnosed or strongly suspected.

Should someone with a resistant infection avoid other people?

Precautions depend on the pathogen, infection site, and healthcare guidance. Follow instructions about hand hygiene, wound coverage, staying home when ill, sexual contact, and contact with vulnerable individuals. Symptoms alone cannot identify a resistant infection.